Francisco V, Tovar S, Conde J, Pino J, Mera A, Lago F, et al
Although not an exhaustive list, the following factors can all lead to joint pain
Medicare GLP-1 Bridge (July 1, 2026): The new Medicare Bridge program will cover Zepbound KwikPen at $50/month for beneficiaries with BMI 35, or BMI 27 with weight-related comorbidities
This was part of the conditions that allow an athlete to perform at the best level. But now with GLP-1 analogs, the paradigm has changed a little bit because you do not necessarily need to make that effort to control your weight and have this embedded as part of your regimen to perform at the highest level, Rabin explains
At Felix, were very hopeful that the upcoming release of generic semaglutide in Canada will improve both the accessibility and affordability of these treatments for our patients across the country